These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 11334134)

  • 1. Burkholderia cepacia: current clinical issues, environmental controversies and ethical dilemmas.
    Jones AM; Dodd ME; Webb AK
    Eur Respir J; 2001 Feb; 17(2):295-301. PubMed ID: 11334134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health?
    Holmes A; Govan J; Goldstein R
    Emerg Infect Dis; 1998; 4(2):221-7. PubMed ID: 9621192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burkholderia cepacia: medical, taxonomic and ecological issues.
    Govan JR; Hughes JE; Vandamme P
    J Med Microbiol; 1996 Dec; 45(6):395-407. PubMed ID: 8958242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre.
    Ledson MJ; Gallagher MJ; Jackson M; Hart CA; Walshaw MJ
    Thorax; 2002 Feb; 57(2):142-5. PubMed ID: 11828044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans.
    Mahenthiralingam E; Vandamme P; Campbell ME; Henry DA; Gravelle AM; Wong LT; Davidson AG; Wilcox PG; Nakielna B; Speert DP
    Clin Infect Dis; 2001 Nov; 33(9):1469-75. PubMed ID: 11588691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis.
    Kiska DL; Kerr A; Jones MC; Caracciolo JA; Eskridge B; Jordan M; Miller S; Hughes D; King N; Gilligan PH
    J Clin Microbiol; 1996 Apr; 34(4):886-91. PubMed ID: 8815102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Burkholderia cepacia complex.
    Speert DP
    Paediatr Respir Rev; 2002 Sep; 3(3):230-5. PubMed ID: 12376059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak.
    Whiteford ML; Wilkinson JD; McColl JH; Conlon FM; Michie JR; Evans TJ; Paton JY
    Thorax; 1995 Nov; 50(11):1194-8. PubMed ID: 8553277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burkholderia cepacia complex: a contraindication to lung transplantation in cystic fibrosis?
    LiPuma JJ
    Transpl Infect Dis; 2001 Sep; 3(3):149-60. PubMed ID: 11493397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Burkholderia cepacia: a new pathogen causing nosocomial infections].
    Lipowski D; Rzadkiewicz E; Czekalska-Lachowicz E
    Przegl Epidemiol; 2008; 62(1):7-17. PubMed ID: 18536220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of evidence of nosocomial cross-infection by Burkholderia cepacia among Danish cystic fibrosis patients.
    Ryley HC; Ojeniyi B; Høiby N; Weeks J
    Eur J Clin Microbiol Infect Dis; 1996 Sep; 15(9):755-8. PubMed ID: 8922580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia.
    Ledson MJ; Gallagher MJ; Corkill JE; Hart CA; Walshaw MJ
    Thorax; 1998 May; 53(5):432-6. PubMed ID: 9708241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunolocalisation of Burkholderia cepacia in the lungs of cystic fibrosis patients.
    Sajjan U; Corey M; Humar A; Tullis E; Cutz E; Ackerley C; Forstner J
    J Med Microbiol; 2001 Jun; 50(6):535-546. PubMed ID: 11393291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome for patients colonised with Burkholderia cepacia in a Birmingham adult cystic fibrosis clinic and the end of an epidemic.
    Muhdi K; Edenborough FP; Gumery L; O'Hickey S; Smith EG; Smith DL; Stableforth DE
    Thorax; 1996 Apr; 51(4):374-7. PubMed ID: 8733488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppurative mediastinitis secondary to Burkholderia cepacia in a patient with cystic fibrosis.
    George RB; Cartier Y; Casson AG; Hernandez P
    Can Respir J; 2006; 13(4):215-8. PubMed ID: 16779467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular survival and innate immune evasion of Burkholderia cepacia: Improved understanding of quorum sensing-controlled virulence factors, biofilm, and inhibitors.
    Ganesh PS; Vishnupriya S; Vadivelu J; Mariappan V; Vellasamy KM; Shankar EM
    Microbiol Immunol; 2020 Feb; 64(2):87-98. PubMed ID: 31769530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burkholderia cepacia infections in cystic fibrosis.
    Burns JL; Saiman L
    Pediatr Infect Dis J; 1999 Feb; 18(2):155-6. PubMed ID: 10048690
    [No Abstract]   [Full Text] [Related]  

  • 18. Is Burkholderia (Pseudomonas) cepacia disseminated from cystic fibrosis patients during physiotherapy?
    Ensor E; Humphreys H; Peckham D; Webster C; Knox AJ
    J Hosp Infect; 1996 Jan; 32(1):9-15. PubMed ID: 8904368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burkholderia (Pseudomonas) cepacia epidemiology in a cystic fibrosis population: a genome finger-printing study.
    Cazzola G; Amalfitano G; Tonolli E; Perazzoli C; Piacentini I; Mastella G
    Acta Paediatr; 1996 May; 85(5):554-7. PubMed ID: 8827098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Burkholderia cepacia: dangers of a phytopathogen organism for patients with cystic fibrosis].
    Segonds C; Chabanon G
    Ann Biol Clin (Paris); 2001; 59(3):259-69. PubMed ID: 11397673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.